Steven Cohen’s enGene Therapeutics ENGN Stock Holding History
Bought
Maintained
Sold
Other funds holding ENGN
BCM
SL
ACA
Steven Cohen's ENGN Position: Q3 2026 in Review
Steven Cohen increased its enGene Therapeutics (ENGN) stake by 440% in Q3 2026, buying an estimated $114K and bringing the position to 75,552 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #3571.
Steven Cohen first reported a position in ENGN in Q1 2024 and has held it in 11 quarters since. The position peaked at $8.25M in Q3 2025. 60 funds tracked by Wall St. Rank hold ENGN as of Q3 2026.
- Steven Cohen held 75,552 shares of enGene Therapeutics worth $151K as of Q3 2026.
- Steven Cohen bought 61,560 enGene Therapeutics shares in Q3 2026, an estimated $114K.
- enGene Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3571 holding.
- Steven Cohen first reported a position in enGene Therapeutics in Q1 2024 and has held it in 11 quarters since.
- Steven Cohen's enGene Therapeutics position peaked at $8.25M in Q3 2025.
- 60 funds tracked by Wall St. Rank held enGene Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.